Search

everythinglearnresearchcommunity

for

Search:↓

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Male hormones can decrease the ability of immune cells to fight bacteria.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Certain long non-coding RNAs are important for controlling hair growth cycles in sheep.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.